Diagnostics across Europe remain fragmented – requiring companies to coordinate collection, logistics, lab operations, medical oversight, and country-specific compliance. Remi Health has built the digital infrastructure layer that enables payers, digital health companies, pharma, and longevity programs to seamlessly embed compliant, scalable diagnostic testing into patient journeys, without rebuilding operations each time.
Since launch, Remi Health has processed over 1 million diagnostic tests and is currently supporting programs with several major healthcare payers and partners across Europe, working alongside laboratory partners to expand a cross-border network designed for scalable, multi-market diagnostics.
“Decentralised care only works if diagnostics are accessible, trusted, and seamlessly embedded,” said Anthony Bielenstein, Co-CEO of Remi Health. “We remove complexity, so our partners can focus on product innovation, care models, and post-result patient journeys.”
“Labs are the backbone of diagnostics, but most weren’t built for digital-first care,” said Marvin Abert, Co-CEO of Remi Health. “Our platform integrates with lab partners to scale efficiently, utilise unused capacity, and enable access to new sample streams by participating in distributed health journeys without adding operational complexity.”
Remi Health is preparing the launch of its open diagnostics network, expanding beyond core infrastructure with the goal to process 100 million diagnostic tests by 2030.
The new capital will be used to expand Remi Health’s cross-border laboratory network and broaden European coverage, while scaling decentralised collection methods – including at-home, on-site, and partner collection models - to support multi-country diagnostics programs. The company will also advance regulatory coverage across new markets and deepen enterprise partnerships with payers, pharma, and health solution providers.
Remi Health is preparing the launch of its open diagnostics network, expanding beyond core infrastructure with the goal to process 100 million diagnostic tests by 2030, establishing Remi Health as the digital layer for decentralised diagnostics across Europe.
“As diagnostics move beyond the clinic and become more decentralised, competitive advantage shifts to the underlying infrastructure,” said Prof. Silke Sperling, Managing Partner & Founder of Catalpa Ventures. “Remi Health provides the foundational systems that enable this ecosystem to scale.”
“Berlin has become one of Europe’s leading hubs for health innovation, and Remi Health is a strong example of the infrastructure companies emerging from this ecosystem,” said Ulrike Kalapis, Senior Investment Manager at IBB Ventures. “Their platform connects laboratories with the growing demand for decentralised diagnostics - building the kind of scalable, cross-border infrastructure that the market needs.”
